These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14669348)

  • 21. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC; McWilliams D; Watson SA; Mahida YR
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
    Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
    World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity.
    Flisiak I; Zaniewski P; Chodynicka B
    Biomarkers; 2008 Aug; 13(5):549-56. PubMed ID: 18979644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
    de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
    Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
    Maxwell PR; Timms PM; Chandran S; Gordon D
    Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
    George DK; Ramm GA; Powell LW; Fletcher LM; Walker NI; Cowley LL; Crawford DH
    Gut; 1998 May; 42(5):715-20. PubMed ID: 9659170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease.
    Nakamura T; Ushiyama C; Suzuki S; Ebihara I; Shimada N; Koide H
    Am J Nephrol; 2000; 20(1):32-6. PubMed ID: 10644865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
    Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M
    Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis.
    Matsuyama T
    Pediatr Int; 1999 Jun; 41(3):239-45. PubMed ID: 10365570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis.
    Wereszczynska-Siemiatkowska U; Siemiatkowski A; Swidnicka-Siergiejko A; Mroczko B; Dabrowski A
    Z Gastroenterol; 2015 Mar; 53(3):199-204. PubMed ID: 25775169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women.
    Luo XH; Guo LJ; Shan PF; Xie H; Wu XP; Zhang H; Cao XZ; Yuan LQ; Liao EY
    Osteoporos Int; 2006; 17(4):521-6. PubMed ID: 16365830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
    Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
    Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients.
    Ninomiya T; Yoon S; Nagano H; Kumon Y; Seo Y; Kasuga M; Yano Y; Nakaji M; Hayashi Y
    Intervirology; 2001; 44(4):227-31. PubMed ID: 11509885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children.
    Kofla-Dłubacz A; Matusiewicz M; Krzesiek E; Noga L; Iwańczak B
    Adv Clin Exp Med; 2014; 23(1):103-10. PubMed ID: 24596011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury.
    Nagy B; Szélig L; Rendeki S; Loibl C; Rézmán B; Lantos J; Bogár L; Csontos C
    J Crit Care; 2015 Feb; 30(1):162-6. PubMed ID: 25155253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise.
    Lubis AM; Lubis VK
    J Orthop Sci; 2013 Jul; 18(4):519-27. PubMed ID: 23604641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.